搜索临床试验以:Gastric Inhibitory Polypeptide
总计65157个结果
-
Chong Kun Dang PharmaceuticalInje University完全的
-
University Diabetes & Endocrine ConsultantsAmylin Pharmaceuticals, LLC.完全的
-
Centre Hospitalier Universitaire de Besancon终止
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb主动,不招人
-
University of WashingtonAstraZeneca招聘中B细胞非霍奇金淋巴瘤 | 原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 高级别 B 细胞淋巴瘤 | 1 级滤泡性淋巴瘤 | 2 级滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤 | 弥漫性大 B 细胞淋巴瘤,未另行说明 | 转化为弥漫性大 B 细胞淋巴瘤的滤泡性淋巴瘤美国
-
University of LatviaDigestive Diseases Centre GASTRO; Riga East Clinical University Hospital; Academic Histology Laboratory...招聘中
-
Amsterdam UMC, location VUmc完全的2 型糖尿病 | 糖尿病肾病 | 糖尿病肾病 | 肾缺氧 | 肾脏保护 | SGLT2抑制剂 | 格列净荷兰
-
University of Campinas, BrazilEthicon Endo-Surgery完全的
-
Royal Devon and Exeter NHS Foundation TrustNIHR Exeter Clinical Research Facility完全的
-
Norwegian University of Science and TechnologyUniversity of Copenhagen; University of Leeds; St. Olavs Hospital; Namsos Hospital; Norwegian University...完全的
-
University Hospital OstravaUniversity of Ostrava; Vitkovice Hospital, Ostrava, Czech Republic完全的
-
Novartis Pharmaceuticals完全的
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
David Bradley MDMedtronic - MITG完全的
-
Vyne Therapeutics Inc.Premier Research Group plc完全的
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Fred Hutchinson Cancer... 和其他合作者完全的
-
Merck Sharp & Dohme LLC完全的
-
AstraZeneca完全的FGFR 抑制、药代动力学、生物标志物 | ER+乳腺癌捷克共和国, 意大利, 英国, 匈牙利, 德国, 罗马尼亚, 比利时, 法国
-
Amsterdam UMC, location VUmcUniversity of Colorado, Denver; Merck Sharp & Dohme LLC尚未招聘高血压 | 糖尿病 | 糖尿病肾病
-
Dana-Farber Cancer InstitutePfizer完全的
-
Critical Perfusion Inc.National Council of Science and Technology, Mexico; Instituto Nacional de Cardiologia Ignacio... 和其他合作者完全的
-
Puerta de Hierro University HospitalHospital Universitario Ramon y Cajal; Hospitales Universitarios Virgen del Rocío; Hospital Universitario...未知